The Improved Lipid Accumulation Product is an Accurate Index for Predicting Metabolic Syndrome in the Xinjiang Population

Biomed Environ Sci. 2021 Jun 20;34(6):503-507. doi: 10.3967/bes2021.070.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • China / epidemiology
  • Female
  • Humans
  • Lipid Accumulation Product*
  • Male
  • Metabolic Syndrome / epidemiology*
  • Middle Aged
  • Prevalence
  • Risk Assessment / methods*
  • Young Adult